机构：[1]Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.[2]Department of Minimally invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.河南省肿瘤医院[3]Department of Interventional Radiology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China.中山大学附属第三医院[4]Department of Interventional Radiology, Union Hospital of Fujian Medical University, Fuzhou 350001, China.[5]Department of Interventional Radiology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.[6]Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China.[7]Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.浙江大学医学院附属第一医院[8]Department of Interventional Radiology, Eastern Hospital of Hepatobiliary Surgery, Navy Medical University (Second Military Medical University), Shanghai 200438, China.[9]Department of Interventional Radiology, Nantong First People’s Hospital, Nantong 226001, China.[10]Department of Interventional Radiology, Yancheng Third People’s Hospital, Yancheng 224008, China.[11]Department of Minimally Invasive Interventional Therapy, Sun Yat- Sen University Cancer Center, Guangzhou 510060, China.[12]Department of Vascular Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.[13]Department of Interventional Radiology, Hunan Cancer Hospital, Changsha 410031, China.[14]Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.中山大学附属第一医院[15]Department of Interventional Radiology, The Hospital of Nantong University, Nantong 226001, China.[16]Department of Interventional Therapy, Shanxi Tumor Hospital, Taiyuan 030001, China.[17]Department of Interventional Radiology, Tibet Autonomous Region People’s Hospital, Lhasa 850000, China.[18]Department of Interventional Radiology, Ganzhou People’s Hospital, Ganzhou 341000, China.[19]Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.[20]Department of Interventional Radiology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi 214023, China.[21]Department of Minimally Invasive Interventional Therapy, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China.[22]Department of Radiology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.昆明医科大学附属第一医院[23]Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.[24]Department of Interventional Radiology, Affiliated Hospital of Qingdao University, Qingdao 266000, China.[25]Department of Interventional Therapy, Peking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China.[26]Department of Interventional Radiology, Affiliated Cancer Hospital of Shandong First Medical University, Jinan 250117, China.[27]Interventional Therapy Center, The first Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.[28]Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 830011, China.中国医科大学附属盛京医院中国医科大学盛京医院[29]Department of Interventional Oncology, Tianjin Medical University Cancer Hospital, Tianjin 300060, China.[30]Department of Radiology, Tianjin Medical University General Hospital, Tianjin 300052, China.[31]Department of Tumor Interventional Therapy, Fujian Cancer Hospital, Fuzhou 350014, China.[32]Department of Radiology, The Second Xiangya Hospital, Changsha 410011, China.[33]Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Chengdu 610041, China.四川省肿瘤医院[34]Department of Interventional Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.[35]Department of Hepatobiliary Oncology Surgery, Department of Interventional Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang 330029, China.[36]Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang 110001, China.[37]Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 110001, China.华中科技大学同济医学院附属协和医院[38]Department of Interventional Radiology, General hospital of Ningxia Medical University, Yinchuan 110001, China.[39]Department of Interventional Radiology, Guizhou Cancer Hospital, Guiyang 550000, China.[40]Department of Interventional Radiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.[41]Department of Interventional Radiology, Third Affiliated Hospital of Soochow University, Changzhou First Hospital, Changzhou 213004, China.[42]Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University, Changzhou 213003, China.[43]Department of Interventional Therapy, Nantong Tumor Hospital, Nantong 226006, China.[44]Department of Interventional Therapy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China.[45]Department of Interventional Radiology, Affiliated Hospital of Jiangnan University, Wuxi 214122, China.[46]Department of Interventional Radiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.[47]Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China.[48]Department of Interventional Radiology, The Second Hospital of Nanjing, Nanjing 210000, China.[49]Department ofOncology and Vascular Intervention, First Hospital of Shanxi Medical University, Taiyuan 030001, China.[50]Vascular and Interventional Department, Chongqing University Cancer Hospital, Chongqing 400000, China.[51]Department of Interventional Radiology, The Affiliated Hospital of Zunyi Medical College, Zunyi 563000, China.[52]Department of Interventional Therapy, The First Hospital of Jilin University, Changchun 130000, China.[53]Department of Radiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.河北医科大学第四医院[54]Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.江苏省人民医院[55]Department of Radiology, Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, School of Medicine, Lishui Hospital of Zhejiang University, Lishui 323000, China.[56]Department of Interventional Radiology, Shanxi Provincial People’s Hospital, Taiyuan 030012, China.[57]Department of Interventional Medicine, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.[58]Department of Interventional & Vascular Surgery, The Fourth Hospital of Harbin Medical University, Harbin 150001, China.[59]Department of Biostatistics, Nanjing Medical University, Nanjing 211166, China.[60]Zhuhai Interventional Medical Center, Zhuhai Precision Medical Center, Zhuhai People’s Hospital, Zhuhai Hospital Affiliated with Jinan University, Jinan University, Zhuhai 519000, China.
The study was supported by National Key Research and Development Program
(2018YFA0704100, 2018YFA0704104), National Natural Science Foundation of China
(81827805, 82130060), and Jiangsu Provincial Special Program of Medical Science
(BE2019750).
第一作者机构：[1]Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Zhu Hai-Dong,Li Hai-Liang,Huang Ming-Sheng,et al.Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)[J].SIGNAL TRANSDUCTION AND TARGETED THERAPY.2023,8(1):doi:10.1038/s41392-022-01235-0.
APA：
Zhu Hai-Dong,Li Hai-Liang,Huang Ming-Sheng,Yang Wei-Zhu,Yin Guo-Wen...&Teng Gao-Jun.(2023).Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).SIGNAL TRANSDUCTION AND TARGETED THERAPY,8,(1)
MLA：
Zhu Hai-Dong,et al."Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)".SIGNAL TRANSDUCTION AND TARGETED THERAPY 8..1(2023)
医学